Testing effectiveness (Phase 2)WithdrawnNCT02715505
What this trial is testing
Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Who this might be right for
Inherited Metabolic Disorders IMD
Novartis Pharmaceuticals